# Improvement of Liver Function in Liver Cirrhosis Patients After Autologous Mesenchymal Stem Cell Injection:a Phase I-II Clinical Trial

> **NCT00420134** · PHASE1,PHASE2 · COMPLETED · sponsor: **Shahid Beheshti University of Medical Sciences** · enrollment: 30 (estimated)

## Conditions studied

- Liver Failure
- Cirrhosis

## Interventions

- **PROCEDURE:** injection of progenitor of hepatocyte drived from Mesenchymal stem cell

## Key facts

- **NCT ID:** NCT00420134
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2009-05
- **Final completion:** 2009-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2009-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00420134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00420134, "Improvement of Liver Function in Liver Cirrhosis Patients After Autologous Mesenchymal Stem Cell Injection:a Phase I-II Clinical Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00420134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*